Table-I.
Variables | TACE+lenvatinib group (n=46) | TACE group (n=57) | t/ | P |
---|---|---|---|---|
Gender, n (%) | -0.348 | 0.728 | ||
Male | 29 (63.04) | 34 (59.65) | ||
Female | 17 (36.96) | 23 (40.35) | ||
Age, years, mean ± SD | 51.52±6.31 | 52.12±5.71 | -0.507 | 0.614 |
Body weight, kg, n (%) | 0.004 | 0.997 | ||
<60 kg | 25 (54.35) | 31 (54.39) | ||
≥60 kg | 21 (45.65) | 26 (45.61) | ||
ECOG score | -0.184 | 0.854 | ||
0 | 37 (80.43) | 45 (78.95) | ||
1 | 9 (19.57) | 12 (21.05) | ||
Child-Pugh class, n(%) | -0.220 | 0.826 | ||
A | 41 (89.13) | 50 (87.72) | ||
B | 5 (10.87) | 7 (12.28) |